Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Breast Neoplasms 412Carcinoma, Non-Small-Cell Lung 359Neoplasms 327Prostatic Neoplasms 267Colorectal Neoplasms 261Multiple Myeloma 204Lung Neoplasms 195Neoplasm Metastasis 183Leukemia, Myeloid, Acute 158Ovarian Neoplasms 151Pancreatic Neoplasms 143Squamous Cell Carcinoma of Head and Neck 134Melanoma 125Recurrence 99Carcinoma, Renal Cell 99Glioblastoma 96Endometrial Neoplasms 96Stomach Neoplasms 93Precursor Cell Lymphoblastic Leukemia-Lymphoma 92Lymphoma, Non-Hodgkin 92Carcinoma, Hepatocellular 92Head and Neck Neoplasms 91Lymphoma 88Triple Negative Breast Neoplasms 84Uterine Cervical Neoplasms 80Brain Neoplasms 79Sarcoma 78Glioma 75Urinary Bladder Neoplasms 74Lymphoma, Large B-Cell, Diffuse 74

Interventions

enasidenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Sinonasal undifferentiated carcinoma × 30 days × Clear all
NCT06176989 2026-06-03

Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
40 enrolled
CNSSarcoma

Sinonasal undifferentiated carcinoma, Chondrosarcoma, Esthesioneuroblastoma, Olfactory

NCT06814496 2026-05-20

RABBIT

University of Arizona

Phase 1/2 Recruiting
30 enrolled
CNSDermatologicGenitourinaryGynecologicThoracic

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

Data powered by HemOnc (CC BY 4.0) Colophon âš¡